HCID 77150733, compound → HCID 76182073, compound

HRID 1091604Notes

Reaction equation

HRID 1091604 reaction equation
[C:1]([NH:4][CH2:5][CH2:6][N:7]1[CH2:16][CH:15]2[CH:10]([CH2:11][CH2:12][CH2:13][CH2:14]2)[N:9]2[C:17](=[O:46])[C:18]3[N:19]([CH:21]=[C:22]([C:34]([NH:36][CH2:37][C:38]4[CH:43]=[CH:42][C:41]([F:44])=[CH:40][C:39]=4[F:45])=[O:35])[C:23](=[O:33])[C:24]=3[O:25]CC3C=CC=CC=3)[CH2:20][CH:8]12)(=[O:3])[CH3:2]>[Pd]>[C:1]([NH:4][CH2:5][CH2:6][N:7]1[CH2:16][CH:15]2[CH:10]([CH2:11][CH2:12][CH2:13][CH2:14]2)[N:9]2[C:17](=[O:46])[C:18]3[N:19]([CH:21]=[C:22]([C:34]([NH:36][CH2:37][C:38]4[CH:43]=[CH:42][C:41]([F:44])=[CH:40][C:39]=4[F:45])=[O:35])[C:23](=[O:33])[C:24]=3[OH:25])[CH2:20][CH:8]12)(=[O:3])[CH3:2]

Participants

3

Procedure

racemic-4aS,6aS,14aS)-6-[2-(Acetylamino)ethyl]-N-[(2,4-difluorophenyl)methyl]-12-hydroxy-11,13-dioxo-1,2,3,4,4a,5,6,6a,7,11,13,14a-dodecahydropyrido[1′,2′:4,5]pyrazino[1,2-a]quinazoline-10-carboxamide. In a manner similar to that described in example Z-35, from racemic-N-[2-({[(1S,2S)-2-aminocyclohexyl]methyl}amino)ethyl]acetamide hydrochloride (82 mg, 0.349 mmol) and 16a (50 mg, 0.106 mmol) was prepared the title compound (24 mg, 36%). This material was deprotected in a second step similar to the procedure described in example Z-37. Thus, from racemic (4aS,6aS,14aS)-6-[2-(acetylamino)ethyl]-N-[(2,4-difluorophenyl)methyl]11,13-dioxo-12-[(phenylmethyl)oxy]-1,2,3,4,4a,5,6,6a,7,11,13,14a-dodecahydropyrido[1′,2′:4,5]pyrazino[1,2-a]quinazoline-10-carboxamide (24 mg, 0.0379 mmol) and 10% Pd/C (1 mg) was prepared the title compound as a white solid after purification by HPLC. 1H NMR (CDCl3) 12.59 (s, 1H), 10.44 (s, 1H), 8.35 (s, 1H), 7.32 (m, 1H), 6.79 (m, 2H), 5.86 (s, 1H), 4.78 (m, 1H), 4.61-4.50 (m, 3H), 4.30 (m, 1H), 3.35 (m, 1H), 3.18 (m, 1H), 2.96 (m, 1H), 2.76 (m, 2H), 2.48 (m, 1H), 2.19 (m, 1H), 1.89-1.23 (m, 12H): ES+ MS: 544 (M+1).

Sources & evidence

ORD record
ord-c7126f6998ba4cdcb7e152cc93d47ba8
Source dataset
uspto-grants-2012_03
Patent number
US08129385B2

Reaction notes

Loading…